Article
Primary CNS lymphoma commonly expresses immune response biomarkers
1 Jan 2020
Abstract excerpt
Abstract Background Primary central nervous system lymphoma (PCNSL) is rare and there is limited genomic and immunological information available. Incidental clinical and radiographic responses have been reported in PCNSL patients treated with immune checkpoint inhibitors. Materials and Methods To genetically characterize and ascertain if the majority of PCNSL patients may potentially benefit from immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
